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Abstract
OBJECTIVE: To evaluate the clinical efficacy of
Zhenjingdingzhi decoction in treating insomnia
with Qi-deficiency of heart and gallbladder.
METHODS: We conducted a double-blind, random-
ized, controlled trial involving 100 patients with in-
somnia of Qi-deficiency of heart and gallbladder.
Patients were randomly divided into the treatment
group (n = 50) and the control group (n = 50) ac-
cording to a random number table. The treatment
group was given Zhenjingdingzhi decoction, while
the control group was treated with Suanzaoren de-
coction. the pharmacological treatment lasted for 8
weeks. The clinical efficacy was assessed by using
Spiegel scale, Pittsburgh sleep quality index (PSQI)
and Traditional Chinese Medicine (TCM) syndrome
scores.
RESULTS: Comparing Spiegel scores between the
two groups at 4 and 8 weeks, the differences in cu-
rative effect between the two groups were both sig-
nificant (both P < 0.05). The total effective rate was
46% in the treatment group and 27.7% in the con-
trol group at 4 weeks, and 80% and 53.2% at 8
weeks, respectively; After 8 weeks, PSQI scores
showed that the total effective rates differed signifi-
cantly between the two groups (P < 0.01): 84% in
the treatment group and 59.6% in the control
group; In improving sleep quality and sleep dura-
tion, the curative effect of the treatment group was
better than that of the control group (P < 0.05).
TCM syndrome, especially insomnia and palpita-
tion, was improved better in the treatment group
after 8 weeks as compared to that in the control
group (P < 0.05). The total effective rate of the two
groups was 84% and 66%, respectively.
CONCLUSION: Zhenjingdingzhi decoction is effec-
tive and safe for the treatment of insomnia with
Qi-deficiency of heart and gallbladder, especially
for improving sleep quality and sleep duration.
© 2015 JTCM. All rights reserved.
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INTRODUCTION
Studies by the World Health Organization have shown
that almost 30% people in the world suffer from in-
somnia.1 Insomnia is recognized as one of the glob-
al public health issues which are not fully appreciated
or well solved.2 According to epidemiological studies,
the incidence rate of insomnia in China is 10% to
20%.3 In view of these facts, the late Professor Jianhua
Hu, Shanghai famous specialist of Traditional Chinese
Medicine (TCM), extracted Zhenjingdingzhi decoc-
tion to treat insomnia on basis of TCM theory, with
reference to non-prescription medicine and literature,
after decades of clinical trial and error. Zhenjingding-
zhi decoction is modified from Ganmaidazao decoc-
tion, added Tiannanxing (Rhizoma Arisaematis Erubes-
centis), Shichangpu (Rhizoma Acori Tatarinowii), Zhen-
zhumu (Concha Margaritifera Usta), Yuanzhi (Radix
Palygalae) and Danshen (Radix Salviae Miltiorrhizae).
It has the effects of melting Phlegm, regulating Qi, sup-
plementing Qi and nourishing heart to calm mind. In
order to further verify the clinical efficacy of this decoc-
tion on insomnia, we observed and analyzed the thera-
peutic effect by comparing with Suanzaoren decoc-
tion4,5 which is widely approved at home and abroad -
to provide the basis for the clinical treatment of insom-
nia and further explore the new direction of treating
sleep disorders in TCM.
MATERIALS ANDMETHODS
Diagnostic standards
Diagnostic standards of insomnia in Western Medicine
are stipulated by Chinese Classification of Mental Dis-
orders Third Edition (CCMD-3) (F51.0).6 In reference
to Guidelines for Diagnosis and Treatment of Com-
mon Internal Diseases in Chinese Medicine Symptoms
of Chinese Medicine,7 standard for diagnosing in TCM
defines main syndromes as difficulty in falling asleep,
or waking up easily, or waking up frequently during
the night with difficulty of returning to sleep, or keep-
ing sleepless all night, and symptoms persisting for
more than 4 weeks. Also we adopted accompanying
symptoms as follows: dreaminess, vexation, dizziness
and headaches, palpitation and amnesia, fatigue and
lassitude, without other organic disease or inducement
that violate sleep. The main syndromes of Qi-deficien-
cy of heart and gallbladder type referring to Clinic Ter-
minology of Traditional Chinese Medical Diagnosis
and Treatment-Syndromes GB/T16751.2-1997,8 in-
cludes palpitation and timidity, inability to fall asleep,
festless sleep, and the secondary syndromes includes be-
ing susceptible to fright, shortness of breath and lassi-
tude, lack of strength and spontaneous perspiration.
And main feature of tongue and pulse diagnosis: whit-
ish tongue and white fur, stringy-thready pulse.
Inclusion standards
Patients were included if they: (a) conformed to the
above-mentioned diagnostic standards; (b) were 18-65
years old; (c) suffer from insomnia over 4 weeks. All pa-
tients volunteered for this trial and provided written in-
formed consent. The study was approved by Medical
Ethics Committee, Shanghai Longhua Hospital Affili-
ated to Shanghai University of TCM.
Exclusion standards
Patients were excluded if they: (a) did not conform
the diagnostic standards of insomnia or Qi-deficiency
of heart and gallbladder; (b) were < 18 years old
or > 65 years old; (c) were pregnant or lactating; (d)
had diabetes, psychiatric disorder or serious suicidal
tendency.
Eliminating cases and standards of dropout
Patients were eliminated if they: (a) stopped the treat-
ment halfway due to adverse reactions or non-efficacy
reasons; (b) added other drugs; (c) provided incom-
plete data that couldn't be counted; (d) did not com-
plete the therapy as planned; (e) did not conform to in-
clusion standards but were included by mistake.
Patients were considered dropouts of the study if they
had poor compliance, serious adverse reactions, compli-
cations or special physiological changes that made
them inappropriate to continue the trial during the
therapy. When data were statistically analyzed, adverse
reactions should be recorded in the statistics of adverse
reaction and patients who had completed 1/2 of the
therapy should be evaluated the efficacy.
Randomization, double-blind method
From October 2012 to September 2013, a cohort of
100 insomnia patients who visited Neurology Depart-
ment of Longhua Hospital Affiliated to Shanghai Uni-
versity of TCM was recruited and divided randomly in-
to two groups of 50 by their visiting sequence. The
medicine of the two groups was uniformly decocted,
packaged by the Department of Pharmaceutical Prepa-
ration of Longhua Hospital Affiliated to Shanghai Uni-
versity of TCM, Shanghai, China. According to a ran-
dom number table, each study decoction was random-
ly numbered and indicated on the package. The re-
searchers issued the study decoction on the basis of the
subjects visiting sequence which was consistent with
that on the decoction package. At the end of the trial,
we entered the observation data into the established da-
tabase. Primary unblinding was executed when the da-
ta was locked by the statistics professional. And A
group and B group were established. Secondary un-
blinding was executed when the statistics was complet-
ed, and the treatment group and the control group
were definite.
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Therapy
Before the trial was started, all the patients were includ-
ed after one-week washout period. The treatment
group was given Zhenjingdingzhi decoction, which
consisted of Tiannanxing (Rhizoma Arisaematis Erubes-
centis), Shichangpu (Rhizoma Acori Tatarinowii), Zhen-
zhumu (Concha Margaritifera Usta), Yuanzhi (Radix
Palygalae), Danshen (Radix Salviae Miltiorrhizae), Fux-
iaomai (Fructus Tritici Levis), Dazao (Fructus Jujubae),
and Gancao (Radix Glycyrrhizae). The control group
was treated with Suanzaoren decoction which consisted
of Fuling (Poria), Zhimu (Rhizoma Anemarrhenae), Ch-
uanxiong (Rhizoma Chuanxiong), Suanzaoren (Semen
Ziziphi Spinosae) and Prepared Gancao (Radix Glycyr-
rhizae). The above herbs were decocted for 30 min and
concentrated to 150 mL juice twice. The two juices
were mixed together. The dosage of herbal decoction
was 300 mL every day with 150 mL taken orally in the
morning and evening for 8 weeks. All the medicine of
the two groups was uniformly decocted, packaged by
the Department of Pharmaceutical Preparation of Lon-
ghua Hospital Affiliated to Shanghai University of
TCM.
Rules of drug combinations: patients were not allowed
to take other hypnotic, antipsychotics, antidepressant,
hypnotic drugs and any drug that causes insomnia.
Efficacy evaluation
Clinical indexes: we recorded Spiegel scale, Pittsburgh
sleep quality index (PSQI) and TCM syndrome score
at weeks 0, 4 and 8. And we assessed the clinical effica-
cy based on reduction rate. Clinical recovery was de-
fined as reduction rate ≥ 75%. If the reduction rate was
between 50% and 74%, then the clinical efficacy was
marked effective. If the reduction rate was between
25% and 49%, then it was effective. Recovery was in-
valid if the reduction rate was less than 25%. Reduc-
tion rate = (score before treatment – score after treat-
ment) / score before treatment × 100%.
Safety evaluation
Blood routine, urine routine, hepatic and renal func-
tion including aspartate transaminase (AST), alanine
aminotransferase (ALT), creatinine (Cr), blood urea ni-
trogen (BUN), and electrocardiogram were detected be-
fore and after treatment. Adverse events were observed
and recorded during the treatment.
Statistical methods
All the data were analyzed with SPSS 18.0 software
packet (Chicago, IL, USA). Measurement data was ex-
pressed with mean ± standard deviation ( xˉ ± s).
Group t-test was used when measurement data was nor-
mal distribution and homogeneity of variance, other-
wise t-test was used. χ2 test was used for enumeration
data, and rank-sum test was used for ranked data. A P
value < 0.05 was considered to be statistically signifi-
cant.
RESULTS
Comparison of the general statistics before treatment
A hundred patients were recruited and divided random-
ly into the treatment and the control group with 50 pa-
tients in each. During the trial, 3 of the 100 patients
were lost. Of the 3 lost, 1 discontinued for poor com-
pliance and 2 for side effects like headache and vertigo.
They were all from the control group. Finally, 97 pa-
tients completed the trial, 50 in the treatment group
and 47 in the control group. The flow diagram of the
trial is shown in Figure 1.
All the data from these 3 participants were excluded
from the statistical analysis. The two groups had no sig-
nificant differences in age, gender, duration of symp-
toms, PSQI scores or Spiegel scores before treatment
(all P > 0.05) as shown in Table 1. The two groups
were comparable.
Comparison of Spiegel scores before and after
treatment
The total effective rate was 46% in the treatment
group and 27.7% in the control group after 4 weeks of
treatment, and 80% and 53.2% after 8 weeks of treat-
ment, respectively. The statistical test showed that the
differences in curative effect were both significant (P <
0.05). The curative effect in the treatment group was
superior to that in the control group.
Item
Age (years)
Gender (Female/Male) (n)
Duration of symptoms (years)
PSQI score
Spiegel score
TCM syndrome score
Treatment (n=50)
50±11
29/21
7±7
15±3
23±7
11±4
Control (n=50)
49±12
26/24
7±7
16±3
25±7
11±4
t/χ2/Z value
0.792
0.267
﹣0.285
﹣0.241
﹣0.749
﹣0.194
P value
0.430
0.606
0.776
0.810
0.284
0.846
Table 1 Comparison of the general statistics before treatment ( xˉ ± s)
Notes: PSQI: Pittsburgh sleep quality index; TCM: Traditonal Chinese Medicine.
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Comparison of PSQI scores before and after
treatment
After 4 weeks of treatment, the total effective rate was
64% in the treatment group and 42.6% in the control
group. There was no statistical difference (P > 0.05) be-
tween the two groups. After 8 weeks of treatment, the
total effective rate was 84% in the treatment group and
59.6% in the control group. The curative effect of the
treatment group was obviously better than that of the
control group (P < 0.01). In improving sleep quality
and sleep duration, the curative effect of the treatment
group was better than that of the control group (P <
0.05). The mean ranks of the treatment group and the
control group were 55.14 and 54.14, 42.47 and 42.37,
respectively (Table 3, 4).
Comparison of TCM syndrome scores before and
after treatment
The total effective rate was 44% in the treatment
group and 34% in the control group after 4 weeks of
treatment, and 80% and 53.2% after 8 weeks of treat-
ment, respectively. After 4 weeks of treatment, there
was no obvious difference (P > 0.05) between the two
groups. However, the total effective rate in the treat-
ment group was much higher than that in the control
group (P < 0.01). TCM syndrome, especially insomnia
and palpitation, was improved better in the treatment
group after 8 weeks as compared to that in the control
group (P < 0.05). The mean ranks of the treatment
group and the control group were 41.89 and 28.50,
55.39 and 36.98, respectively (Table 5, 6).
Safety
Before and after treatment in the two groups, blood
routine, urine routine, electrocardiogram examination,
hepatic and renal function revealed no abnormal chang-
es in any patients in either group. This indicated that
Zhenjingdingzhi decoction was safe. Among 100 pa-
Figure 1 Flow diagram of the trial
Assessed to eligibility (n = 100)
Randomized
Treatment group (n = 50) Control group (n = 50)
Analyzed (n = 50) Analyzed (n = 47) 3 were lost to
follow-up
Analyzed (n = 50) Analyzed (n = 47)
Base line
Follow-up at 4 weeks
Follow-up at 8 weeks
Time
After 4 weeks
of treatment
After 8 weeks
of treatment
Group
Treatment
Control
Treatment
Control
n
50
47
50
47
Ineffective
(n)
27
34
10
22
Improved
(n)
12
10
10
7
Obvious
effective (n)
9
2
20
12
Recovery
(n)
2
1
10
6
Total effective rate
(%)
46.0
27.7
80.0
53.2
P
value
0.036a
0.013a
Table 2 Comparison of curative effects in Spiegel scores between the two groups after 4 and 8 weeks of treatment
Notes: the treatment group was given Zhenjingdingzhi decoction (150 mL, each time, twice a day) and the control group was treated with
Suanzaoren decoction (150 mL, each time, twice a day). aP < 0.05 as compared with the data of control group.
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tients which were included in the trial, 6 patients had
adverse reactions (1 in treatment group and 5 in con-
trol group). In the control group, 2 cases withdrew
from the study due to mouth and tongue sore, diarrhea
and pharyngodynia. And 4 cases had gastrointestinal
adverse reactions such as flatulence and nausea. All the
adverse reactions were mild and disappeared or alleviat-
ed 1 week after withdrawal of drug.
Time
After 4 weeks
of treatment
After 8 weeks
of treatment
Group
Treatment
Control
Treatment
Control
n
50
47
50
47
Ineffective
(n)
18
27
8
19
Improved
(n)
17
10
19
17
Obvious effective
(n)
14
8
15
9
Recovery
(n)
1
2
8
2
Total effective
rate (%)
64.0
42.6
84.0
59.6
P
value
0.072
0.007a
Notes: the treatment group was given Zhenjingdingzhi decoction (150 mL, each time, twice a day) and the control group was treated with
Suanzaoren decoction (150 mL, each time, twice a day). aP < 0.01 compared with the data of control group. PSQI: Pittsburgh sleep quali-
ty index.
Table 3 Comparison of curative effects in PSQI scores between the two groups after 4 weeks and 8 weeks of treatment
Item
Sleep quality
Time to fall asleep
Sleep duration
Sleep efficiency
Sleep disorder
Hypnotics
Daytime functions
Group
Treatment
Control
Treatment
Control
Treatment
Control
Treatment
Control
Treatment
Control
Treatment
Control
Treatment
Control
n
50
47
50
45
50
46
47
44
50
46
26
23
48
45
Ineffective
(n)
9
20
27
31
17
24
26
28
36
30
8
13
22
27
Improved
(n)
13
10
4
3
10
10
5
2
0
0
3
2
18
13
Obvious
effective (n)
26
15
18
8
20
12
7
8
13
15
3
2
3
3
Recovery
(n)
2
2
1
3
3
0
9
6
1
1
12
6
5
2
55.14
42.47
51.02
44.64
54.14
42.37
47.74
44.14
46.96
50.17
28.19
21.39
50.43
43.34
Mean
rank
P
value
0.018a
0.194
0.027a
0.461
0.484
0.075
0.162
Table 4 Comparison of curative effects in each item of PSQI after 8 weeks of treatment
Notes: the treatment group was given Zhenjingdingzhi decoction (150 mL, each time, twice a day) and the control group was treated with
Suanzaoren decoction (150 mL, each time, twice a day). aP < 0.05 as compared with the data of control group. PSQI: Pittsburgh sleep
quality index.
Time
After 4 weeks
of treatment
After 8 weeks
of treatment
Group
Treatment
Control
Treatment
Control
n
50
47
50
47
Ineffective
(n)
28
31
8
16
Improved
(n)
20
14
23
23
Obvious
effective (n)
2
2
16
8
Recovery
(n)
0
0
3
0
Total effective
rate (%)
44.0
34.0
84.0
66.0
P
value
0.349
0.006a
Table 5 Comparison of curative effects in TCM syndrome between the two groups after 4 and 8 weeks of treatment
Notes: the treatment group was given Zhenjingdingzhi decoction (150 mL, each time, twice a day) and the control group was treated with
Suanzaoren decoction (150 mL, each time, twice a day). aP < 0.01 as compared with the data of control group. TCM: Traditonal Chinese
Medicine.
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DISCUSSION
With social and economic development, more people
suffer from insomnia.9 Many western hypnotics have
been developed in recent years, such as benzodiazepine
derivatives, non-benzodiazepine hypnotics, and z-drugs
like zolpidem, zopiclone, eszopiclone and zaleplon.10-12
Each drug acts on neurotransmitters or receptors to
produce sedative and hypnotic effects. However, the
medications have short durations of action, and some
have a risk of tolerance or abuse.13 They may also cause
impairments in memory and cognitive function, espe-
cially benzodiazepine derivatives.14 Thus, developing ef-
fective medicines without side effects to treat insomnia
is particularly urgent. Insomnia, is called Bu Mei in
TCM, and early documented as mu bu ming (un-
closed eyes), wo Bu An (unease sleep), bu De Wo (un-
able to lie down) in Huang Di Nei Jing.15 Tai Ping
Sheng Hui Fang16 of Song Dynasty points out that in-
somnia due to insufficiency of the gallbladder-Qi has
close relation with heart. And injury of heart-Qi, hid-
den pathogen in gallbladder and deficiency-cold of liv-
er and gallbladder lead to difficulty in lying down. It al-
so maintains the relationship between heart and gall-
bladder and began to emphasize the combination thera-
py for heart and gallbladder. It might be said that the
book developed the new category of treatment varia-
tion for insomnia due to insufficiency of the gallblad-
der-Qi.17 Yi Zong Jin Jian says that insufficiency of gall-
bladder-Qi causing timidity is essential to difficulty in
lying down due to fear.18 As stated in the Shen Shi Zun
Sheng Shu·Bu Mei,19 timidity of heart and gallbladder
and susceptibility to fright cause nightmares, dysphoria
and hypersomnia. It shows that debility of heart and
gallbladder leads to being vulnerable to panic and rest-
less sleep. And sometimes tension and anxiety because
of the sudden shock make decision function of gall-
bladder damaged which means it is easy to feel uneasy
and produces symptoms like insomnia, dreaminess
and easily awakened, etc.20 Zhu et al 21 collected 120 pa-
tients with insomnia and the syndrome differentiation
shows that types of Qi-deficiency of heart and gallblad-
der, hyperactivity of fire due to Yin-deficiency and defi-
ciency of both heart and spleen accounted for 60% of
the subjects. Chen et al 22 adopted a syndrome differen-
tiation of 75 insomnia patients and the result showed
that over 30% of the patients were the Qi-deficiency of
heart and gallbladder type. Thus it can be seen that in-
somnia is deficiency-excess complex, but deficiency
syndrome is in the majority in clinic, especially the
type of Qi-deficiency of heart and gallbladder. Accord-
ing to its pathogenic characteristics, nourishing heart
and tranquilizing mind are the main ideas for syn-
drome differentiation and treatment. Suanzaoren de-
coction obtained from Jin Kui Yao Lue of Zhang-
zhongjing for the treatment of insomnia with deficien-
cy syndromes23 and its effectiveness had been verified
by TCM doctors of past dynasties.24 Gu Jin Ming Yi
Fang Lun25 acclaimed it as a miraculous decoction for
TCM syndrome
Gallbladder
timidity and
susceptibility to
fright
Insomnia
Dreaminess
Palpitation
Shortness
of breath
Shortness of
breath lack of
strength
Anepithymia
Group
Treatment
Control
Treatment
Control
Treatment
Control
Treatment
Control
Treatment
Control
Treatment
Control
Treatment
Control
n
36
38
49
47
40
43
37
26
28
22
46
45
8
8
0
Never
13
9
4
3
12
12
27
11
16
7
13
5
6
4
1
Sometimes
18
23
26
12
20
13
6
13
9
10
20
23
2
1
2
Often
4
3
9
15
7
12
4
1
4
4
11
12
0
3
3
Always
1
3
10
17
1
6
0
1
0
1
2
5
0
0
Mean
rank
35.11
39.76
41.89
55.39
37.98
45.74
28.50
36.98
23.28
29.59
41.36
50.74
7.13
9.88
P
value
0.299
0.012a
0.122
0.037a
0.104
0.069
0.181
Table 6 Comparison of curative effects in each item of TCM syndromes between the two groups after 8 weeks of treatment
Notes: the treatment group was given Zhenjingdingzhi decoction (150 mL, each time, twice a day) and the control group was treated with
Suanzaoren decoction (150 mL, each time, twice a day). aP < 0.05 as compared with the data of control group. TCM: Traditonal Chinese
Medicine.
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treating consumptive disease and blood-deficiency in
liver. In Ben Cao Yi Du,26 it is the best decoction for
treating consumptive disease and insomnia with weak-
ness and irritability. A large number of domestic and
foreign clinical research and modern pharmacological
experimental studies showed that Suanzaoren decoc-
tion had a better sleep improvement effect.27-29 This
study used Suanzaoren decoction as the control drug to
evaluate the clinical efficacy of Zhenjingdingzhi decoc-
tion on treating insomnia. Zhenjingdingzhi decoction
was extracted by the late Professor Jianhua Hu, Shang-
hai famous specialist of TCM, originating from the
therapy theory of tranquilizing mind by nourishing the
heart. It was based on the famous prescription Gan-
maidazao decoction from Prescriptions of the Jin Kui
Yao Lue·Fu Ren Za Bing30 of Zhang Zhongjing, adding
Danshen (Radix Salviae Miltiorrhizae), Shichangpu
(Rhizoma Acori Tatarinowii), Yuanzhi (Radix Palygalae),
etc. Danshen (Radix Salviae Miltiorrhizae) has the
property of nourishing blood and tranquilizing mind.
Gancao (Radix Glycyrrhizae), Fuxiaomai (Fructus Tritici
Levis) and Dazao (Fructus Jujubae) have the function of
alleviating pain and make a good effect on nourishing
heart-Qi and tranquilizing mind. Shichangpu (Rhi-
zoma Acori Tatarinowii), Yuanzhi (Radix Palygalae),
and Tiannanxing (Rhizoma Arisaematis Erubescentis)
can eliminate phlegm for resuscitation and relieve sta-
sis. Zhenzhumu (Concha Margaritifera Usta) has the ef-
fect on checking and descending the upward rebellious
Qi. Compatibility of all the medicine makes therapeu-
tic effect on nourishing heart, tranquilizing mind, re-
suscitation and relieve stasis. This study indicates that
Zhenjingdingzhi decoction is effective and safe for the
treatment of insomnia with Qi-deficiency of heart and
gallbladder, especially for improving sleep quality and
sleep duration.
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